comparemela.com
Home
Live Updates
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission : comparemela.com
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
PLYMOUTH MEETING, Pa., May 23, 2023 /PRNewswire/ -- INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related... | May 23, 2023
Related Keywords
,
Thomas Hong ,
Jennie Willson ,
Pharmaceuticals Inc ,
European Committee For Orphan Medicinal Products ,
Exchange Commission ,
Drug Administration ,
European Commission ,
European Union ,
Regulatory Affairs ,
Recurrent Respiratory Papillomatosis ,
European Committee ,
Orphan Medicinal Products ,
Vice President ,
Annual Report ,
Quarterly Report ,
Inovio Pharmaceuticals ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Plymouth ,
Bay ,
023 ,
Inovio ,
Biotechnology ,
Company ,
Ocused ,
N ,
Developing ,
End ,
Commercializing ,
Na ,
Medicines ,
Treat ,
Rotect ,
People ,
Rom Ino Us45773h2013 ,
comparemela.com © 2020. All Rights Reserved.